pharmatimes.com
in-depth news, features and insights for the pharmaceutical and healthcare sectors
4/30/2026
UK spin‑out speeds up development and reduces animal testing
Boehringer Ingelheim reports significant reductions in weight
4/29/2026
Partnership to support selection of first neoantigen therapy candidate
Collaboration aims to create integrated platform from discovery to IND submission
4/28/2026
Lead asset shows systemic, dose‑dependent anti‑tumour activity
US study marks company’s second clinical trial of ovarian cancer therapy
4/27/2026
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants
Greater flexibility for people with systemic lupus erythematosus
4/13/2026
Company expects two‑year dfs data by q1 2028
New authorisation offers additional option for patients with lvef ≥40%
4/9/2026
Partnership to develop next‑generation T‑cell engagers for solid tumours
First patient dosed as DOMISOL study grows beyond Australia
4/8/2026
Ardena has appointed Paul Edwards as Chief People Officer
A journey from community pharmacy to medical leadership
4/7/2026
Subcutaneous delivery shows IV‑level efficacy in moderate to severe TED
Study expands development of the antibody into hepatocellular carcinoma
4/2/2026
Abselion has appointed Dale Gordon as Chair of the Board of Directors
It’s the start of a beautiful friendship, as Jess takes to the page
4/1/2026
Updated dosing offers meaningful clinical benefit
Company says treatment shows strong efficacy and convenient dosing profile
3/31/2026
Specialist group to review preclinical and clinical proposals ahead of funding decision
European Commission authorises therapy for children and adults with early‑onset disease
3/30/2026
Phase 3 studies report meaningful reductions in exacerbations across broad patient groups
CHMP decision allows self‑administration from phase 5 for people with multiple myeloma
3/26/2026
Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m
AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO)
Compressed air is among the largest energy expenses in pharmaceutical manufacturing and must remain entirely contamination-free.
3/25/2026
Axplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy
Helus Pharma, a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief People Officer, effective immediately
3/24/2026
DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its SYNTAX platform.
